Gamma Vaccines’ lead product is GammaFlu

Matome Others
    Monday, November 08, 2021 at 22:11
    Gamma Vaccines’ lead product is GammaFlu® that offers broader spectrum immunity to different influenza viruses.
    Flu Vaccine, Shots, Avian Influenza Vaccine Poultry Australia
    Gamma Vaccines Pty Ltd is an Australian company targeting primarily the human and avian influenza market.

    Formed in July 2009, the company is developing a cross-protective influenza virus vaccine, GammaFlu®, designed to replace current seasonal injectable flu vaccines with an easy-to-administer, broader-spectrum intranasal vaccine. The Company’s products also hold the prospect of being able to be stockpiled for use as an immediate first response to any new influenza pandemic. In addition, Gamma Vaccines is developing a vaccine that can provide better protection against highly pathogenic avian influenza in poultry. The Company is also conducting research on vaccines for preventing bacterial pneumonia.

    Gamma Vaccines’ proprietary technology was invented by leading researchers from The Australian National University’s John Curtin School of Medical Research and The University of Adelaide’s School of Molecular Life Sciences. The company has attracted significant equity investments from Australian, Indonesian & US investors and been awarded numerous grants from the Australian Capital Territory and the Commonwealth Government of Australia.

    Founded by experienced early-stage managers and the inventors themselves, the company is currently negotiating with several partners in Asia and Europe to commence clinical trials for applications in both human and animal vaccination markets.

    E-mail: [email protected]

    Telephone: +61 420 942 824

    Write to:
    Gamma Vaccines Pty Limited
    PO Box 4435 Manuka ACT 2603 Australia



    Please Login or Signup to comment

    More Matome

    MBB Auditing - Best Auditing Services In Dubai and Sharjah
    Monday, November 08, 2021 at 16:50
    13 view

    Latest Matome

    Posted by: